Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- befree-2016 importedOn "2016-02-19" NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_assertion wasGeneratedBy ECO_0000203 NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_assertion wasDerivedFrom befree-2016 NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_assertion SIO_000772 20721741 NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_assertion evidence source_evidence_literature NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.
- NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_assertion description "[Specifically, in familial cancer syndromes, DHPLC has been reported as a genetic screening tool for the risk of developing breast and ovarian cancer (BRCA1), von Hippel Lindau disease (VHL), Cowden syndrome (PTEN), and Multiple Endocrine Neoplasia types 1 and 2 (MEN1 and RET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833672.RAd3bLtDG2iy6QUJla-jdueRPeVAYq1jcO693P411a2f8130_provenance.